New vesicular ampicillin-loaded delivery systems for topical application: characterization, in vitro permeation experiments and antimicrobial activity

被引:40
作者
Carafa, M
Marianecci, C
Lucania, G
Marchei, E
Santucci, E
机构
[1] Univ G Annunzio, Fac Pharm, Dip Sci Farmaco, I-66100 Chieti, Italy
[2] Univ Roma La Sapienza, Fac Pharm, Dip Chim Tecn Sost Biol Att, Rome, Italy
[3] Univ Roma La Sapienza, Fac Med, Dip Med Sperimentale & Patol, Rome, Italy
关键词
polysorbate; 20; surfactant vesicles; gellan; ampicillin; antimicrobial activity; skin permeation;
D O I
10.1016/j.jconrel.2003.10.022
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
In this paper, the experimental conditions for preparing ampicillin-loaded surfactant vesicles (SVs) are described. Our studies are focused on the potential use of a vesicular polymeric dispersion as ampicillin delivery system for topical application. The main components of the formulation are uncharged and charged SVs loaded with ampicillin and dispersed in a gellan solution. The following issues are addressed: the drug encapsulation efficiency (e.e.), the kinetic of drug release from the delivery systems, the antimicrobial activity of vesicle-entrapped ampicillin. The in vitro permeation experiments through a synthetic lipophilic barrier (Silastic((TM))) and through porcine skin are carried out to evaluate the potential use as a dermal formulation. The use of both a synthetic and a biological membrane allows to discriminate between the effects related to variations of thermodynamic parameters and those correlated to biological factors. The release rate of ampicillin is increased by encapsulation in neutral and negatively charged SVs and the permeation rate was slowed by dispersion of drug-loaded SVs in gellan solution. Finally, studies of antimicrobial activity on prepared systems evidenced that ampicillin encapsulated in SVs exhibit a higher activity than the free drug. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 33 条
[1]
Comparison of the antibacterial activities of ampicillin, ciprofloxacin, clarithromycin, telithromycin and quinupristin/dalfopristin against intracellular non-typeable Haemophilus influenzae [J].
Ahrén, IL ;
Karlsson, E ;
Forsgren, A ;
Riesbeck, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (06) :903-906
[2]
Surfactant effects on the in vitro percutaneous absorption of diclofenac sodium [J].
Arellano, A ;
Santoyo, S ;
Martín, C ;
Ygartua, P .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (02) :307-312
[3]
DELIVERY OF ANTIMICROBIALS TO INFECTED TISSUE MACROPHAGES [J].
BAKKERWOUDENBERG, IAJM .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 17 (01) :5-20
[4]
BIGBY M, 1986, JAMA-J AM MED ASSOC, V256, P3358
[5]
EFFECT OF NONIONIC SURFACTANTS ON TRANSDERMAL DRUG DELIVERY .1. POLYSORBATES [J].
CAPPEL, MJ ;
KREUTER, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 69 (02) :143-153
[6]
Morphological analysis of the interaction of charged surfactant vesicles (SVs) with human cultured cells [J].
Carafa, M ;
Lucania, G ;
Marchei, E ;
Dolo, V ;
Giammatteo, M ;
Torrisi, MR ;
Santucci, E ;
Pavan, A .
BIOTECHNIC & HISTOCHEMISTRY, 1999, 74 (02) :77-84
[7]
Preparation and properties of new unilamellar non-ionic/ionic surfactant vesicles [J].
Carafa, M ;
Santucci, E ;
Alhaique, F ;
Coviello, T ;
Murtas, E ;
Riccieri, FM ;
Lucania, G ;
Torrisi, MR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 160 (01) :51-59
[8]
CHANTEUX H, 2002, J PHARM BELG, P34
[9]
DIGIULIO A, 1991, INT J PHARM, V74, P183
[10]
AMPICILLIN-LOADED LIPOSOMES AND NANOPARTICLES - COMPARISON OF DRUG LOADING, DRUG RELEASE AND INVITRO ANTIMICROBIAL ACTIVITY [J].
FATTAL, E ;
ROJAS, J ;
ROBLOTTREUPEL, L ;
ANDREMONT, A ;
COUVREUR, P .
JOURNAL OF MICROENCAPSULATION, 1991, 8 (01) :29-36